Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRIX Nurix Therapeutics

休市中 07-25 16:00:00 EDT

11.52

-0.01

-0.09%

盘后11.52

+0.00+0.02%

17:18 EDT

最高11.70	最低11.45	成交量47.69万
今开11.55	昨收11.53	日振幅2.17%
总市值8.81亿	流通市值6.68亿	总股本7,645万
成交额550.88万	换手率0.82%	流通股本5,796万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":11.52,"timestamp":1753473600000,"preClose":11.53,"halted":0,"volume":476863,"hourTrading":{"tag":"盘后","latestPrice":11.5219,"preClose":11.52,"latestTime":"17:18 EDT","volume":9963,"amount":114774.083,"timestamp":1753478294035},"delay":0,"floatShares":57962173,"shares":76449355,"eps":-2.602838,"marketStatus":"休市中","change":-0.01,"latestTime":"07-25 16:00:00 EDT","open":11.55,"high":11.7,"low":11.45,"amount":5508831.05449,"amplitude":0.021683,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.602838,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":11.53,"preHourTrading":{"tag":"盘前","latestPrice":11.75,"preClose":11.53,"latestTime":"08:17 EDT","volume":1116,"amount":13128.303708,"timestamp":1753445820917},"postHourTrading":{"tag":"盘后","latestPrice":11.5219,"preClose":11.52,"latestTime":"17:18 EDT","volume":9963,"amount":114774.083,"timestamp":1753478294035},"volumeRatio":0.712836568410238,"impliedVol":0.6012,"impliedVolPercentile":0.108},"requestUrl":"/m/hq/s/NRIX","defaultTab":"news","newsList":[{"id":"2550640477","title":"UBS Adjusts Price Target on Nurix Therapeutics to $26 From $30, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550640477","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550640477?lang=zh_cn&edition=full","pubTime":"2025-07-10 20:25","pubTimestamp":1752150352,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics (NRIX) has an average rating of buy and mean price target of $30.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"瑞银将Nurix Therapeutics目标价从30美元调整至26美元，维持买入评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRIX"],"gpt_icon":0},{"id":"1198497678","title":"Nurix Therapeutics Q2销售额同比大增264.34%，远超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1198497678","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198497678?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:30","pubTimestamp":1752136248,"startTime":"0","endTime":"0","summary":"7月10日，生物医药股$Nurix Therapeutics(NRIX)$盘前暴涨逾30%！该公司第二季度销售额同比大增264.34%，远超市场预期>>","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0f9e54d7803d3bf82b30fa8895eed68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nurix Therapeutics Q2销售额同比大增264.34%，远超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NRIX","BK4007"],"gpt_icon":0},{"id":"1161625950","title":"异动解读 | 业绩超预期，Nurix Therapeutics盘前大涨28.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161625950","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161625950?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:21","pubTimestamp":1752135660,"startTime":"0","endTime":"0","summary":"周四盘前，生物技术公司Nurix Therapeutics股价大幅飙升28.60%，引发市场广泛关注。这一显著涨幅主要源于公司最新发布的季度财报远超市场预期。根据公司公告，截至5月31日的季度财报显示，Nurix Therapeutics调整后每股亏损为0.52美元，明显优于分析师平均预期的0.73美元亏损。值得注意的是，分析师对Nurix Therapeutics的评级普遍较为积极。这种积极的市场情绪，加上超预期的财报表现，共同推动了公司股价的大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0f9e54d7803d3bf82b30fa8895eed68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"1152122372","title":"异动解读 | 业绩超预期，Nurix Therapeutics夜盘大涨16.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152122372","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152122372?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:37","pubTimestamp":1752133061,"startTime":"0","endTime":"0","summary":"生物技术公司Nurix Therapeutics在夜盘交易中股价大涨16.31%，引起投资者广泛关注。这一显著涨幅主要源于公司最新发布的季度财报超出市场预期。根据公司公告，截至5月31日的季度财报显示，Nurix Therapeutics调整后每股亏损为0.52美元，明显优于分析师平均预期的0.73美元亏损。值得注意的是，目前分析师对Nurix Therapeutics的评级普遍较为积极。这种积极的市场情绪可能进一步推动了股价的上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0f9e54d7803d3bf82b30fa8895eed68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"2550668201","title":"Nurix Therapeutics Q2 EPS $(0.52) Beats $(0.75) Estimate, Sales $44.056M Beat $17.009M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668201","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550668201?lang=zh_cn&edition=full","pubTime":"2025-07-10 04:02","pubTimestamp":1752091364,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.75) by 30.76 percent. This is a 26.76 percent increase over losses of $(0.71) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"Nurix Therapeutics第二季度每股收益(0.52)美元超出预期(0.75)美元，销售额4405.6万美元超出预期1700.9万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/07/46331162/nurix-therapeutics-q2-eps-0-52-beats-0-75-estimate-sales-44-056m-beat-17-009m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX"],"gpt_icon":0},{"id":"2543858886","title":"RBC Raises Price Target on Nurix Therapeutics to $28 From $27, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2543858886","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543858886?lang=zh_cn&edition=full","pubTime":"2025-06-13 18:21","pubTimestamp":1749810097,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics (NRIX) has an average rating of buy and mean price target of $30.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"加拿大皇家银行将Nurix Therapeutics目标价从27美元上调至28美元，维持跑赢大盘和投机风险","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RBC Raises Price Target on Nurix Therapeutics to $28 From $27, Keeps Outperform, Speculative Risk","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRIX"],"gpt_icon":0},{"id":"2537664748","title":"Nurix Therapeutics, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537664748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537664748?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:06","pubTimestamp":1747764362,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时06分，Nurix Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020602aa2c946c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2534276316","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534276316?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056725,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Nurix Therapeutics, Inc.股票出现波动，股价急速上涨5.16%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221320594f481a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","NRIX","BK4139"],"gpt_icon":0},{"id":"2534151819","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.05%报9.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534151819?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:19","pubTimestamp":1746721174,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时19分，Nurix Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509001934aa2c87f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2529352935","title":"Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529352935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529352935?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:43","pubTimestamp":1745336605,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时43分，Nurix Therapeutics, Inc.股票出现异动，股价急速上涨5.31%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.83%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422234325aa2c7683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2529338536","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529338536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529338536?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:39","pubTimestamp":1745246371,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时39分，Nurix Therapeutics, Inc.股票出现波动，股价急速上涨5.47%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223932a4613096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2528711090","title":"Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711090","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528711090?lang=zh_cn&edition=full","pubTime":"2025-04-17 20:33","pubTimestamp":1744893215,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Thursday that the US Food and Drug Administration has cleared an investigational new drug application for its oral IRAK4 degrader GS-6791/NX-0479, allowing for a phase 1 trial to start, which is expected to begin in Q2.The company said it is to receive $5 million from Gilead Sciences  for the IND clearance and remains eligible for up to $420 million in potential future milestone payments as part of a 2019 collaboration agreement.Nurix said GS-6791/NX-0479 has potential applications in rheumatology and dermatology, including rheumatoid arthritis and atopic dermatitis.Under the terms of the 2019 collaboration agreement, Nurix and Gilead Sciences  are looking to discover, develop, and commercialize a pipeline of up to five therapies for cancer and other diseases, the company said.Nurix shares were over 8% higher while Gilead shares were 0.2% higher in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Nurix表示FDA批准口服IRAK4降解剂用于炎症性疾病；分享盘前","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","BK4550","LU0058720904.USD","LU0109394709.USD","LU0234570918.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK6054","IE00B7SZLL34.SGD","BK4588","BK4568","LU1066053197.SGD","LU0320765992.SGD","BK4566","BK4583","LU0289739699.SGD","LU1430594728.SGD","BK4532","BK4585","IE00BKVL7J92.USD","LU1839511570.USD","IE0002270589.USD","IE00B3T34201.USD","LU2089984988.USD","LU2468319806.SGD","BK4139","LU0889565916.HKD","LU1571399168.USD","43A.SI","NRIX","GILD","BK6520","LU1585245621.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2527724493","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527724493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527724493?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:08","pubTimestamp":1744812494,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时08分，Nurix Therapeutics, Inc.股票出现波动，股价急速跳水5.19%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220814a6bcabc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4007","BK4139"],"gpt_icon":0},{"id":"1185750574","title":"异动解读 | 生物科技公司Nurix Therapeutics盘中大涨5.08%，分析师维持买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1185750574","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185750574?lang=zh_cn&edition=full","pubTime":"2025-04-10 02:00","pubTimestamp":1744221635,"startTime":"0","endTime":"0","summary":"周三盘中，生物科技公司Nurix Therapeutics股价出现显著上涨，涨幅达5.08%，引起了投资者的广泛关注。这一强劲表现反映了市场对该公司前景的积极看法。消息面上，知名投资银行Stifel最新发布的研究报告显示，分析师维持对Nurix Therapeutics的\"买入\"评级，但将目标价从36美元小幅下调至35美元。Nurix Therapeutics是一家专注于开发创新疗法的生物制药公司，主要致力于发现、开发和商业化用于调节细胞蛋白水平的口服小分子疗法，以治疗癌症和免疫紊乱。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 生物科技公司Nurix Therapeutics盘中大涨5.08%，分析师维持买入评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"2526635395","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526635395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526635395?lang=zh_cn&edition=full","pubTime":"2025-04-09 22:40","pubTimestamp":1744209634,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日22时40分，Nurix Therapeutics, Inc.股票出现波动，股价快速下挫5.08%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.83%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040922403497335930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2526620683","title":"Stifel：维持Nurix Therapeutics(NRIX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2526620683","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526620683?lang=zh_cn&edition=full","pubTime":"2025-04-09 21:44","pubTimestamp":1744206294,"startTime":"0","endTime":"0","summary":"Stifel：维持Nurix Therapeutics(NRIX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至35.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/09214449437941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2525802165","title":"Nurix Therapeutics, Inc.盘中异动 快速下挫5.26%报9.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525802165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2525802165?lang=zh_cn&edition=full","pubTime":"2025-04-07 21:34","pubTimestamp":1744032865,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时34分，Nurix Therapeutics, Inc.股票出现异动，股价快速下跌5.26%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.87%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213425a450fbd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4007","BK4139"],"gpt_icon":0},{"id":"2524826855","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大跌6.06%报10.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524826855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2524826855?lang=zh_cn&edition=full","pubTime":"2025-04-03 21:38","pubTimestamp":1743687486,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时38分，Nurix Therapeutics, Inc.股票出现波动，股价快速下跌6.06%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213806a44cbd34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2519858260","title":"Nurix Therapeutics, Inc.盘中异动 早盘急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519858260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2519858260?lang=zh_cn&edition=full","pubTime":"2025-03-13 22:33","pubTimestamp":1741876408,"startTime":"0","endTime":"0","summary":"北京时间2025年03月13日22时33分，Nurix Therapeutics, Inc.股票出现波动，股价快速下跌5.09%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031322332898a66055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2516658359","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658359?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:35","pubTimestamp":1741016156,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时35分，Nurix Therapeutics, Inc.股票出现异动，股价急速跳水5.18%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032335579637bcd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nurixtx.com","stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":-0.0086},{"period":"3month","weight":-0.0035},{"period":"6month","weight":-0.422},{"period":"1year","weight":-0.4525},{"period":"ytd","weight":-0.3885}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.157},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1833},{"period":"ytd","weight":0.0871}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库，该公司已经建立了一个集成的发现平台DELigase，以识别和开发针对E3连接酶的新药物候选。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.063877},{"month":2,"riseRate":0.2,"avgChangeRate":-0.007659},{"month":3,"riseRate":0.2,"avgChangeRate":-0.071924},{"month":4,"riseRate":0.4,"avgChangeRate":-0.043438},{"month":5,"riseRate":0.4,"avgChangeRate":-0.000824},{"month":6,"riseRate":0.6,"avgChangeRate":0.118065},{"month":7,"riseRate":0.8,"avgChangeRate":0.090028},{"month":8,"riseRate":0.6,"avgChangeRate":0.053338},{"month":9,"riseRate":0.2,"avgChangeRate":0.013466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0754},{"month":11,"riseRate":0.4,"avgChangeRate":0.106468},{"month":12,"riseRate":0.4,"avgChangeRate":0.034689}],"exchange":"NASDAQ","name":"Nurix Therapeutics","nameEN":"Nurix Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nurix Therapeutics,NRIX,Nurix Therapeutics股票,Nurix Therapeutics股票老虎,Nurix Therapeutics股票老虎国际,Nurix Therapeutics行情,Nurix Therapeutics股票行情,Nurix Therapeutics股价,Nurix Therapeutics股市,Nurix Therapeutics股票价格,Nurix Therapeutics股票交易,Nurix Therapeutics股票购买,Nurix Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}